Claim Missing Document
Check
Articles

Found 2 Documents
Search

The Impact of the Internet on Pharmaceutical Marketing: Benefits, Challenges, and Ethical Considerations Rehan Haider
International Journal of Integrative Research Vol. 1 No. 1 (2023): January, 2023
Publisher : MultiTech Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (400.492 KB) | DOI: 10.59890/ijir.v1i1.4

Abstract

The Internet has revolutionized pharmaceutical marketing, enabling companies to reach and engage effectively with their target audience. Websites, social media platforms and online advertisements have become important tools for disseminating information about medicines, treatments and health services. Personalization of content and campaigns is made possible through data analytics and targeted advertising, increasing the effectiveness of marketing efforts. However, challenges and ethical issues are associated with online pharmaceutical marketing. Complying with regulatory guidelines and providing accurate, evidence-based information is critical to maintaining trust and credibility. Pharmaceutical companies must carefully handle patient data, ensure compliance with data protection laws, and obtain proper approvals. In addition, the Internet empowers patients, enabling them to search for and share information about healthcare products and services. Patient communities and online forums serve as valuable platforms for patients to discuss their experiences and support one another. Pharmaceutical companies must actively listen and engage in meaningful dialogue to build trust and address their concerns. In conclusion, the Internet has transformed pharmaceutical marketing by offering new channels of communication, personalized messaging and patient engagement.
The Determinants of Studies Productiveness in Ethical Drug Discovery Rehan Haider
International Journal of Integrative Research Vol. 1 No. 1 (2023): January, 2023
Publisher : MultiTech Publisher

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (473.478 KB) | DOI: 10.59890/ijir.v1i1.6

Abstract

In 1971, the Pharmaceutical producer's affiliation participants spent approximately $360 million on research and development.l In 1991 they spent $8.nine billion, an increase of over 2300 percent. whilst industry income has grown in step with research expenditures, there has been no full-size increase inside the range of the latest tablets introduced. Why have costs increased so dramatically? Breakthroughs in pharmaceutical research can lay the foundation for qualitative improvements in the quality of existence and big discounts within the price of healthcare, however escalating healthcare fees have centered attention on each factor of healthcare expenditure and feature led several observers to question the apparent decline within the productiveness of pharmaceutical studies. This bankruptcy hopes to contribute to the controversy by  exploring the issue inside the context of a broader take look at the determinants of studies productivity inside the discovery of ethical drugs. We draw upon detailed facts set compiled from the internal records of the ten most important pharmaceutical companies. The statistics set permits us to distinguish among studies (or discoveries) and improvement expenses at an enormously dis aggregated stage. as instance, in the standard magnificence of cardiovascular cures, we can observe the distinctions amongst fields together with hypertension, cardio tonic, and blood-associated conditions. This study  first presents a few descriptive facts from the sample. Our pattern corporations show a lengthy-term decline in productiveness this is a feature of the industry as a whole. each study and development expenditures have improved dramatically in actual phrases, even as the output of important patents has fallen,2 and the wide variety of capsules observed have remained about regular.